Cargando…
SARSCOV-2 vaccine associated with primary cutaneous peripheral T cell lymphoma
Autores principales: | Montoya, VH Garcia, Cardona, L Gonzalez, Morales, S, Ospina, JA, Rueda, X |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier LTD.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484838/ http://dx.doi.org/10.1016/S0959-8049(22)00617-7 |
Ejemplares similares
-
Immunotherapeutic potential of varicella vaccine in smoldering and cutaneous adult T-cell leukemia/lymphoma
por: Amano, M, et al.
Publicado: (2014) -
P1353: EFFICACY OF SARSCOV2 VACCINATION IN PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANTATION. A MULTICENTER EXPERIENCE
por: Stirparo, L., et al.
Publicado: (2022) -
Cutaneous T-cell lymphoma (CTCL) exacerbation after viral vector COVID-19 vaccination
por: Panou, Evdoxia, et al.
Publicado: (2021) -
Cutaneous anaplastic large cell lymphoma in HIV exceptional case in Algeria
por: Rais, M, et al.
Publicado: (2014) -
Impact of liver enzymes on SARSCoV-2 infection and on the severity of clinical disease
por: Servín-Caamaño, A., et al.
Publicado: (2020)